Search Results - "Goldberg, John M"

Recommendations for the Use of WBC Growth Factors: American Society of Clinical Oncology Clinical Practice Guideline Update by Smith, Thomas J, Bohlke, Kari, Lyman, Gary H, Carson, Kenneth R, Crawford, Jeffrey, Cross, Scott J, Goldberg, John M, Khatcheressian, James L, Leighl, Natasha B, Perkins, Cheryl L, Somlo, George, Wade, James L, Wozniak, Antoinette J, Armitage, James O

“…To update the 2006 American Society of Clinical Oncology guideline on the use of hematopoietic colony-stimulating factors (CSFs). The American Society of…”
Get full text

Childhood T-Cell Acute Lymphoblastic Leukemia: The Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium Experience by GOLDBERG, John M, SILVERMAN, Lewis B, LEVY, Donna E, DALTON, Virginia Kimball, GELBER, Richard D, LEHMANN, Leslie, COHEN, Harvey J, SALLAN, Stephen E, ASSELIN, Barbara L

“…T-cell acute lymphoblastic leukemia (T-ALL) accounts for 10% to 15% of newly diagnosed cases of childhood acute lymphoblastic leukemia (ALL). Historically,…”
Get full text

Tivantinib (ARQ 197), a Selective Inhibitor of MET, in Patients With Microphthalmia Transcription Factor―Associated Tumors: Results of a Multicenter Phase 2 Trial by WAGNER, Andrew J, GOLDBERG, John M, DAVIS, Ian J, FENG CHAI, WAGHORNE, Carol, SCHWARTZ, Brian, DEMETRI, George D, DUBOIS, Steven G, CHOY, Edwin, ROSEN, Lee, PAPPO, Alberto, GELLER, James, JUDSON, Ian, HOGG, David, SENZER, Neil

“…Microphthalmia transcription factor (MITF)-associated (MiT) tumors are a family of rare malignancies, including alveolar soft part sarcoma (ASPS), clear cell…”
Get full text

Immunotherapy of sarcomas by Goldberg, John M

“…PURPOSE OF REVIEWTo describe the current advances in immunotherapy and how they can be applied to sarcoma. This review will discuss the recent literature and…”
Get full text

Active immunotherapy using dendritic cells in the treatment of glioblastoma multiforme by Bregy, Amade, Wong, Theresa M, Shah, Ashish H, Goldberg, John M, Komotar, Ricardo J

“…Abstract Objective Glioblastoma multiforme, the most common malignant brain tumor still has a dismal prognosis with conventional treatment. Therefore, it is…”
Get full text

Nelarabine, etoposide, and cyclophosphamide in relapsed pediatric T‐acute lymphoblastic leukemia and T‐lymphoblastic lymphoma (study T2008‐002 NECTAR) by Whitlock, James A., Malvar, Jemily, Dalla‐Pozza, Luciano, Goldberg, John M., Silverman, Lewis B., Ziegler, David S., Attarbaschi, Andishe, Brown, Patrick A., Gardner, Rebecca A., Gaynon, Paul S., Hutchinson, Raymond, Huynh, Van T., Jeha, Sima, Marcus, Leigh, Messinger, Yoav, Schultz, Kirk R., Cassar, Jeannette, Locatelli, Franco, Zwaan, C. Michel, Wood, Brent L., Sposto, Richard, Gore, Lia

“…Children with relapse of T‐cell acute lymphoblastic leukemia (T‐ALL) or lymphoblastic lymphoma (T‐LBL) have a dismal prognosis, largely due to difficulty…”
Get full text

Extended progression-free survival in two patients with alveolar soft part sarcoma exposed to tivantinib by Goldberg, John M, Gavcovich, Tara, Saigal, Gaurav, Goldman, Jonathan W, Rosen, Lee S

Get full text

From vision to reality: deploying the immune system for treatment of sarcoma by Wilky, Breelyn A, Goldberg, John M

“…Modern immunotherapy advances including checkpoint inhibitors and adoptive T cell therapy have created a new era of cancer treatment, with significant…”
Get more information

Rhabdomyosarcoma in Adults: New Perspectives on Therapy by Ruiz-Mesa, Catalina, Goldberg, John M., Coronado Munoz, Alvaro J., Dumont, Sarah N., Trent, Jonathan C.

“…Opinion statement Rhabdomyosarcoma (RMS) is well known as a pediatric disease. Most of the knowledge, like biology, genetics, and treatments of this disease,…”
Get full text

Biologic Activity of Autologous, Granulocyte-Macrophage Colony-Stimulating Factor Secreting Alveolar Soft-Part Sarcoma and Clear Cell Sarcoma Vaccines by Goldberg, John M, Fisher, David E, Demetri, George D, Neuberg, Donna, Allsop, Stephen A, Fonseca, Catia, Nakazaki, Yukoh, Nemer, David, Raut, Chandrajit P, George, Suzanne, Morgan, Jeffrey A, Wagner, Andrew J, Freeman, Gordon J, Ritz, Jerome, Lezcano, Cecilia, Mihm, Martin, Canning, Christine, Hodi, F Stephen, Dranoff, Glenn

“…Alveolar soft-part sarcoma (ASPS) and clear cell sarcoma (CCS) are rare mesenchymal malignancies driven by chromosomal translocations that activate members of…”
Get full text

Immunotherapy in sarcoma: a new frontier by Wilky, Breelyn A, Goldberg, John M

“…Sarcomas are rare cancers of soft tissue and bone, and remain incurable when refractory to standard multimodality treatments. With the recent advances in…”
Get more information

Rhabdomyosarcoma in Adults: New Perspectives on Therapy by Ruiz-Mesa, Catalina, Goldberg, John M., Coronado Munoz, Alvaro J., Dumont, Sarah N., Trent, Jonathan C.

Get full text

Cardiac failure 30 years after treatment containing anthracycline for childhood acute lymphoblastic leukemia by Goldberg, John M, Scully, Rebecca E, Sallan, Stephen E, Lipshultz, Steven E

“…In 1977, a 5-year-old girl diagnosed with acute lymphoblastic leukemia was treated on Dana-Farber Cancer Institute Childhood Acute Lymphoblastic Leukemia…”
Get full text

Tivantinib (ARQ 197), a selective inhibitor of MET, in patients with microphthalmia transcription factor–associated tumors by Wagner, Andrew J., Goldberg, John M., DuBois, Steven G., Choy, Edwin, Rosen, Lee, Pappo, Alberto, Geller, James, Judson, Ian, Hogg, David, Senzer, Neil, Davis, Ian J., Chai, Feng, Waghorne, Carol, Schwartz, Brian, Demetri, George D.

“…BACKGROUND: Microphthalmia transcription factor (MITF)‐associated (MiT) tumors are a family of rare malignancies, including alveolar soft part sarcoma (ASPS),…”
Get full text

Phase 1 trial of autologous dendritic cell vaccination with imiquimod immunomodulation in children and adults with refractory sarcoma by Dhir, Aditi, Koru-Sengul, Tulay, Grosso, James, D'Amato, Gina Z., Trucco, Matteo M., Rosenberg, Andrew, Gilboa, Eli, Goldberg, John M., Trent, Jonathan C., Wilky, Breelyn A.

“…Abstract only 11542 Background: Sarcomas are rare, heterogeneous, and aggressive neoplasms that often affect otherwise healthy individuals. Patients with…”
Get full text

Clinical practice guidelines for cancer care: utilization and expectations of the practicing oncologist by Dillmon, Melissa, Goldberg, John M, Ramalingam, Suresh S, Mayer, Robert J, Loehrer, Patrick, Van Poznak, Catherine

“…ASCO produces guidelines for oncologists, utilizing a systematic review process. Although this resource-intense process results in authoritative and widely…”
Get full text

A phase I window, dose escalating and safety trial of metformin in combination with induction chemotherapy in relapsed refractory acute lymphoblastic leukemia: Metformin with induction chemotherapy of vincristine, dexamethasone, doxorubicin, and PEG-asparaginase (VPLD) by Barredo, Julio C., Goldberg, John M., Hale, Gregory, Gill, Jonathan Benjamin, Setty, Bhuvana, Smith, Tiffany, Lee, Jae K, Reed, Damon R.

“…Abstract only…”
Get full text

Phase 1 open-label, multiple ascending dose trial of AGEN1884, an anti-CTLA-4 monoclonal antibody, in advanced solid malignancies by Wilky, Breelyn A., Kumthekar, Priya, Wesolowski, Robert, Hwang, Jimmy J., Raizer, Jeffrey J., Gentry, Carleen, Ross, Ainsley, Drouin, Elise, Wilson, Nicholas, Shebanova, Olga, Goldberg, John M., Buell, Jennifer, Stein, Robert Benjamin, Cuillerot, Jean-Marie

“…Abstract only 3075 Background: AGEN1884 is a fully human IgG1 monoclonal antibody targeting the co-inhibitory protein cytotoxic T lymphocyte-associated protein…”
Get full text

Phase I open-label, ascending dose trial of AGEN1884, an anti-CTLA-4 monoclonal antibody, in advanced solid malignancies: Dose selection for combination with PD-1 blockade by Wilky, Breelyn A., Kumthekar, Priya, Wesolowski, Robert, Hwang, Jimmy J., Park, Steven I., Proscurshim, Igor, Yuan, Guojun, Dupont, Christopher D, Shebanova, Olga, Cuillerot, Jean-Marie, Dow, Edward, Raizer, Jeffrey J., Gentry, Carleen, Ross, Ainsley, Drouin, Elise, Wilson, Nicholas, Goldberg, John M., Buell, Jennifer, Stein, Robert Benjamin

“…Abstract only…”
Get full text

Abstract CT080: A phase I study of CPI-613 (devimistat) in combination with chemoradiation in patients with pancreatic ductal adenocarcinoma by Kamgar, Mandana, Khan, Husain Yar, Aboukameel, Amro, Bannoura, Sahar F., Chung, Brian Y., Szabo, Aniko, Li, Yiwei, Hallak, Mohammed Najeeb Al, Philip, Philip A., George, Ben, Christians, Kathleen K., Evans, Douglas B., Tsai, Susan, Erickson, Beth, Goldberg, John M., Azmi, Asfar S., Hall, William A.

“…Background: Local tumor progression is a cause of significant mortality and morbidity in patients (pts) with inoperable pancreatic ductal adenocarcinoma…”
Get full text